![Shaw Sorooshian](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Shaw Sorooshian served as the Chief Medical Officer & Vice President at Moberg Pharma AB from 2018 to 2020.
Prior to this, he pursued his undergraduate degree at The University of Edinburgh.
Anciens postes connus de Shaw Sorooshian
| Sociétés | Poste | Fin |
|---|---|---|
| MOBERG PHARMA AB | Directeur Technique/Scientifique/R&D | 30/07/2020 |
Formation de Shaw Sorooshian
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
5
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The University of Edinburgh
 The University of Edinburgh Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moberg Pharma AB
 Moberg Pharma AB Pharmaceuticals: MajorHealth Technology Develops and commercializes medical products | Health Technology |
